Article Text

Download PDFPDF
Randomised controlled trial
Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches

Statistics from Altmetric.com

Footnotes

  • Twitter Follow Anne Corbett at @DrAnneCorbett

  • Funding NIHR, Maudsley Biomedical Research Unit for Dementia.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.